Search

Your search keyword '"Michael H. Alderman"' showing total 148 results

Search Constraints

Start Over You searched for: Author "Michael H. Alderman" Remove constraint Author: "Michael H. Alderman" Topic blood pressure Remove constraint Topic: blood pressure
148 results on '"Michael H. Alderman"'

Search Results

1. Salt sensitivity: state of the science

2. Dietary Sodium: Where Science and Policy Diverge

Catalog

Books, media, physical & digital resources

3. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT

4. Pressor Response to Initial Blood Pressure Monotherapy Is Associated With Cardiovascular Mortality

5. Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment?

6. ATTAINED BLOOD PRESSURE LEVELS AND CARDIOVASCULAR EVENTS AND MORTALITY AMONG OLDER WOMEN

7. THE HYPERTENSION PARADIGM

8. Renin-Angiotensin System Blockers May Create More Risk Than Reward for Sodium-Depleted Cardiovascular Patients With High Plasma Renin Levels

9. Mortality and Morbidity During and After the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

10. Enduring Direct Association of Baseline Plasma Renin Activity With All-Cause and Cardiovascular Mortality in Hypertensive Patients

11. Hypertension Control at Physicians' Offices in the United States

12. Sodium, blood pressure, and cardiovascular disease

13. Reply to SN Thornton1

14. Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

15. Evidence Relating Dietary Sodium to Cardiovascular Disease

16. Renal dysfunction and ischemic heart disease mortality in a hypertensive population

17. Exercise and Cardiovascular Outcomes by Hypertensive Status: NHANES I Epidemiological Follow-up Study, 1971–1992

18. Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease?

19. The IOM Report Fails To Detect Evidence to Support Dietary Sodium Guidelines

20. [Untitled]

21. Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy

22. Dietary Sodium and Cardiovascular Health in Hypertensive Patients

23. Original Papers

24. Low sodium diet after DASH: Has the situation changed?

25. Salt, blood pressure and health: a cautionary tale

26. Myocardial function and geometry in hypertensive subjects with low levels of afterload

27. Design of the omapatrilat in persons with enhanced risk of atherosclerotic events (OPERA) trial

28. Response to 'Salt Intake and Mortality'

29. Assessing the Associations of Sodium Intake With Long-Term All-Cause and Cardiovascular Mortality in a Hypertensive Cohort

30. Response to 'Article on sodium intake should include ethnic disclaimer'

31. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials

32. Salt, Blood Pressure, and Human Health

33. Dietary Potassium Intake and Stroke Mortality

34. Diabetes and Cardiovascular Events in Hypertensive Patients

35. Can we Stratify Risk to Guide Therapy Presented at WHO-ISH Meeting. September 29, 1998. Fukuoka, Japan

36. Salt and blood pressure in children

37. JNC V revisited: Standard of care or individualized treatment for hypertension?

38. Urinary sodium excretion and myocardial infarction in hypertensive patients: a prospective cohort study

39. Plasma Renin Activity: A Risk Factor for Myocardial Infarction in Hypertensive Patients

40. The Limitations of Transferring Evidence from Clinical Trials to the Care of Individual Patients

41. Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view

42. Influence of Obesity on Left Ventricular Midwall Mechanics in Arterial Hypertension

43. Blood pressure J-curve: is it cause or effect?

44. Antihypertensive drug therapy The effect of JNC criteria on prescribing patterns and patient status through the first year

45. Absolute Cardiovascular Risk: The Basis for Deciding to Treat

46. Quantifying Cardiovascular Risk in Hypertension

47. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease

48. Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

49. A New Paradigm for Blood Pressure Management

50. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults